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Glibenclamide is an antidiabetic drug used for the treatment of diabetes type II. The
chemistry of this product makes its analysis difficult especially at low concentrations (1,
2). The analytical method used in validation of the cleaning process should fulfil the fol-
lowing requirements: the ability to detect the target substance(s) at levels consistent with
the acceptance criteria and the ability to detect the target substance(s) in the presence of
other materials that may also be present in the sample (selectivity).
Molecularly imprinted polymer (MIP), as a new specific recognition synthetic poly-
mer (3), could be used as a novel support for solid phase extraction (SPE) of glibencla-
mide residues. Separation depends on interactions between the template and polymer
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The performance of a molecularly imprinted polymer
(MIP) as selective packing material for solid-phase ex-
traction (SPE) of residual glibenclamide in an industrial
process was investigated. MIP was prepared using 4-vinyl-
pyridine as monomer, ethylenedimethacrylate as cross
linker, 2,2’-azobis-2-methylpropionitrile as initiator and
dimethyl formamide as porogen. Use of acetonitrile as a
rebinding solvent allows good recognition of the gliben-
clamide template. It was found that this polymer can be
used for determination of trace levels of glibenclamide
with a recovery percentage that could reach 87.1 %.
Furthermore, the synthesized MIP showed higher selec-
tivity towards glibenclamide than other compounds such
as glimepiride and metformine. The synthesized MIP ena-
bled direct determination of the target contaminant after
an enrichment step that allowed quantification of gliben-
clamide at a concentration as low as 0.016 mg L–1. Com-
bination of high performance liquid chromatography
with MIP-SPE could be successfully used for quality
control of pharmaceuticals during the cleaning process
in the production of dry drug forms.
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synthesized from monomer(s), cross linker and porogen. The interactions can involve co-
valent or non-covalent bonding (4, 5). Consequently, these polymeric materials recognize
and bind, selectively, only the template molecules. Hence, the choice of the chemical enti-
ties used to synthesize MIP plays a crucial role since these compounds have a significant
influence on the morphology, physicochemical properties and performance of these poly-
meric materials (6, 7).
In our case, a new MIP was synthesized and used as solid phase support for gli-
benclamide extraction. Furthermore, its selectivity was evaluated by equilibrium bind-
ing and rebinding experiments. Finally, glibenclamide-MIP was applied to demonstrate
the level of a pharmaceutical industry cleaning process.
EXPERIMENTAL
Chemicals
Glibenclamide, glimepiride and metformine (Fig. 1) were kindly provided by Siphat
(Tunisia). Ethylenedimethacrylate (EDMA), 4-vinylpyridine (4-VP) and AIBN [2,2’-azo-
bis-2-methylpropionitrile) were purchased from Sigma Aldrich (France). Acetonitrile, di-
methylformamide and methanol were purchased from Scahrlau (France). Ultra pure water
corresponding to European Pharmacopea (8) requirements was provided from Siphat (Tu-
nisia). Drug tablets (Glib 5) were also provided from Siphat.
Apparatus and chromatographic conditions
High performance liquid chromatographic analysis was performed on a Waters Al-
liance HPLC system, model Waters 2695, consisting of a quaternary pump, a Rheodyne
injector and a dual wavelength detector model Waters 2487 (all from the USA). Sepa-
ration was performed according to European Pharmacopea (8) using a Sunfire C18 column
(250 x 4.6 mm i.d., 5 µm particle size). The mobile phase was a mixture of 45 % phase A
and 55 % phase B. The mobile phase A consisted of acetonitrile/water (5 : 95, V/V) con-
taining 0.2 % triethylamine and adjusted to pH 3.0, while mobile phase B consisted of mo-
bile phase A, water and acetonitrile (2 : 6.5 : 91.5, V/V/V). The flow rate was 1 mL min–1
and the injection volume was 20 µL.
Preparation of the molecularly imprinted polymer
A non-covalent molecular imprinting approach was followed to prepare the MIP
and the non-imprinted polymer (NIP). The pre-polymerization mixture of glibenclamide
(template) (25 mg, 0.0506 mmol) dissolved in DMF (3 mL). 4-VP (monomer) (4 mmol,
453 µL) was added to a previously prepared solution and the mixture was stirred for
5 min at ambient temperature. To this, EDMA was added (5 mmol, 970 µL) and the mix-
ture was stirred for 5 min. Then AIBN (10 mg) was added and the mixture was stirred
for further 10 min. Finally, the mixture was sonicated for 10 min and sparged with nitro-
gen for 5 min. After 24 h of thermopolymerisation at 60 °C, the resultant hard polymer
was removed. Then, the rigid polymer was ground with a pestle in a mortar and sieved
using a 50-mm sieve to obtain fine particles (30–40 µm) measured by optical microscopy.
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Polymer washing and cartridge preparation
To remove the template bound within the polymer matrix, the resulting powder was
washed for 30 min with a mixture of methanol and acetic acid (90 : 10, V/V). The washing
procedure was repeated until no more glibenclamide could be detected in the washing
solution. The particles were then washed with methanol and water to remove residual
acetic acid, followed by oven drying. In parallel, a non-imprinted control polymer was
also synthesized, in the absence of template, following the same procedure as described
above. After the washing step, two cartridges (MIP and NIP) were prepared by introduc-
ing 100 mg of the powder into a 10 mL polypropylene syringe secured by frits. Before use,
each cartridge was activated by treatment with the same solvent used in the loading step.
In the loading step, 2 mL of glibenclamide solution (50 mg L–1) prepared in a mixture of
acetonitrile and water (6 : 4, V/V) was passed through the cartridge. The washing step in-
cluded 1 mL of acetonitrile. Finally, glibenclamide was eluted with 1 mL of methanol.
Batch rebinding studies and adsorption isotherm
For batch rebinding studies, 50 mg of dry MIP and NIP particles were placed in a
100-mL Erlenmeyer flask and incubated for 24 h with 50 mL of glibenclamide solution
(100 mg L–1). Different solvent mixtures containing acetonitrile, methanol, tetrahydro-
furan or a mixture of acetonitrile and water were tested. After the period of incubation,
the supernatant was removed, filtered and analyzed by HPLC in order to measure the
residual glibenclamide (amount not bound).
For adsorption isotherm studies, 50 mg of polymer was placed in an Erlenmeyer flask
containing 50 mL of glibenclamide (10–300 mg L–1) prepared in acetonitrile/water (6 : 4,
V/V). The solution was shaken for 24 hours at room temperature at a speed of 150 rpm.
Upon equilibration, all samples were filtered through a 0.45-µm filter to minimize the
interference of particles during analysis. The residual concentration of glibenclamide was
analyzed by HPLC. The amount of glibenclamide was determined from the difference in
concentrations at the beginning and at the end of each batch test.
Sampling of glibenclamide and testing of the equipment surface
Swab sampling technique was used and sites were chosen with care in an attempt
to cover the entire equipment surface area. To determine the potential carryover into the
subsequent product, it was important that, as a minimum, 16 swab sites from worst case
locations on the equipment were selected according to pharmacopeial guidelines (8). Be-
fore analysis, 10 mL of rinse solution was loaded onto the conditioned MIP cartridge.
The amount of glibenclamide found in 10 mL rinsate was selectively retained by the MIP
cartridge. After a washing step with 1 mL acetonitrile, glibenclamide was recovered with
1 mL methanol.
RESULTS AND DISCUSSION
Recognition ability of MIP
In order to evaluate the binding affinity and to establish the optimum conditions
under which the template could be recognized by the corresponding MIP, a standard so-
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lution of glibenclamide was initially prepared in various solvents such as dimethylfor-
mamide, methanol and acetonitrile. Results (Fig. 2) showed that the prepared polymer
allowed better selectivity for glibenclamide (³ 90 %) with acetonitrile as a solvent than
with methanol or dimethylformamide. Furthermore, the results obtained illustrate that
MIP showed higher affinity for glibenclamide than NIP, indicating that MIP was really
imprinted (Fig. 3). This imprinting phenomenon could be explained by the hydrogen bond
between glibenclamide proton and pyridine group of the monomer (9, 10).
Adsorption isotherms
Adsorption isotherms are useful in understanding the adsorption interaction mecha-
nism of glibenclamide with the MIP surface. The binding isotherms of glibenclamide
(Fig. 4) show that the amount of glibenclamide bound to the MIP at equilibrium increas-
ed with concentration until reaching saturation at approximately 45 ± 1 mg g–1. In con-
268
R. Lahsini et al.: Preparation and application of a molecularly imprinted polymer for determination of glibenclamide residues, Acta
Pharm. 63 (2013) 265–275.
Fig. 2. The effect of acetonitrile, dimethylformamide and methanol as the rebinding solution on gli-
































Fig. 1. Chemical structure of glibenclamide, glimepiride and metformine.
trast, the adsorption amount of glibenclamide with NIP did not exceed 12 mg g–1. These
results suggest that the binding to the polymer was mostly caused by specific binding to
a limited number of binding sites in the polymer network, rather than by non-specific
adsorption (11).
The adsorption isotherm is a function that describes the relationship between the
equilibrium concentration of bound (B) and free (F) analyte in the polymer. The re-ar-
ranged Freundlich model describes B as a power function of F, according to:
B = a Fm
or it could be logarithmically transformed into a linear form.
The two parameters, a and m, reflect the distribution of binding sites of different
binding strengths which are present in the polymer. Term a is a Freundlich parameter
related to the binding affinity and term m is the heterogeneity index with values from
zero to one, one indicating homogeneity and zero indicating heterogeneity of the sites.
This empirical equation is suitable for highly heterogeneous surfaces (12, 13).
The obtained data of glibenclamide adsorption equilibrium (Fig. 4) was analyzed
using the Langmuir, Schatcard and Freundlich isotherm models. The experimental data
into better transformed Freundlich isotherm model than the Langmuir or Schatcard as
the experimental data fall on a straight line when plotted in a log B vs. log F form (Figs.
4b, c) allowing for the determination of experimental sorption parameters (R², m, a). Data
obtained for the Freundlich model concerning MIP and NIP are presented in Table I. The
heterogeneity index m obtained for NIP is higher than that of MIP, which is in agreement
with previous studies (14, 15). As can be seen from the results, the lower m value of MIP
indicates a more heterogeneous property than that of NIP. These observations could be
attributed to the formation of imprints on the MIP surface. However, the obtained value
of m for NIP is sufficiently distant from the unity explaining the role of heterogeneity of
the adsorption sites. Within this diversity, we can suppose that certain adsorption sites
of NIP have an affinity towards glibenclamide equivalent to that of sites found in MIP.
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Fig. 3. Illustration of glibenclamide-imprinted polymer and its interactions.
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Fig. 4. a) Adsorption isotherm of glibenclamide onto MIP and NIP; b) and c) The re-arranged Freundlich




Application of SPE to HPLC analysis
The selectivity of MIP for glibenclamide was investigated using glimepiride and met-
formine as interfering compounds. HPLC results (Fig. 5a) showed the separation of gli-
benclamide, glimepiride and metformine from a standard mixture before and after MIP-
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Fig. 5. HPLC chromatograms of standard mixture solutions: a) initial mixture before MIP-SPE, b) mix-
ture after elution through MIP’s cartridge and c) mixture after polymer washing with acetonitrile and
elution with methanol. Chromatographic conditions as indicated in the experimental part. A – metfor-




-SPE. These results showed the selectivity of the chromatographic method (Table II) as
well as the selectivity of the MIP cartridge. This shows that glibenclamide was more
strongly retained washed MIP cartridge (Figs. 5b, c) than glimepiride and metformine.
Limit of detection (LOD) and limit of quantification (LOQ)
The limit of detection and quantitation were calculated as a signal-to-noise ratio (S/N)
of 3:1 and 10:1, respectively. The LOD of glibenclamide was found to be 0.04 mg L–1 and
the LOQ 0.15 mg L–1.
Recovery study
The capacity of a MIP corresponds to the amount of a glibenclamide that can be re-
tained on the MIP under given conditions. It was investigated by measuring the reco-
veries on the MIP for trace concentrations of glibenclamide. It was performed after per-
colation of 10 mL of different concentrations of glibenclamide (10–100 µg L–1) through a
cartridge of MIP. After a washing step with 1 mL of acetonitrile, glibenclamide was eluted
with 1 mL of methanol. Fig. 6 shows that recovery obtained with glibenclamide-MIP
cartridge varied between 63.4 and 87.1 %.
Assay after the cleaning process in a production line
After the production of glibenclamide tablets (Glib 5), a part of the equipment surface
(10 cm2) was wiped with acetonitrile and the rinsing solution was analyzed by HPLC. The
results obtained (Fig. 7a) showed that no glibenclamide could be detected (concentration
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Table I. Freundlich parameters for MIP and NIP
Polymer R² m a
MIP 0.993 0.367 0.285
NIP 0.976 0.582 1.466
R2 – coefficient of determination; m (slope) and a (intercept) of a line.
Table II. Chromatographic parameters
Parameter Metformine Glimepiride Glibenclamide
Theoretical plates (N) 733 5880 6881
Capacity factor (k') 2.36 21.82 25.75
Selectivity (a)a – 6.794 1.172
Resolution (Rs)a – 23.08 3.16
HETP (mm)b 341 43 36
a With respect to previous peak.
b HETP – height equivalent to the theoretical plate.
< LOD, namely 0.04 mg L–1). Therefore, a step of MIP-enrichment was used. In this step
and before HPLC analysis, 10 mL of rinse solution was loaded onto the conditioned MIP
cartridge. After a washing step with 1 mL acetonitrile, glibenclamide was recovered with
1 mL methanol. Fig. 7b shows a highly detectable and quantifiable glibenclamide peak,
indicating that glibenclamide was present in the rinse solution. It was found that this
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Fig. 6. Recovery of glibenclamide from standard solutions using MIP and NIP (mean ± SD, n = 3).
Fig. 7. Chromatograms of rinse solution: a) without MIP-SPE, b): after MIP-SPE enrichment and elu-
tion with methanol. Chromatographic conditions as indicated in the experimental part. A – metfor-
mine, B – glimepiride.
a)
b)
concentration of glibenclamide was 0.016 mg L–1. These results indicate that residual gli-
benclamide was present in the rinse solution, but could not be detected if the analysis of
rinse solution was done without a MIP-enrichment step.
CONCLUSIONS
The applied worst-case approach for pharmaceutical safety and main risks assess-
ment helps figure out the relevant safety issues based on multi-product manufacture cross-
-contamination. In a preventive action, a new molecularly imprinted polymer was syn-
thesized and used as solid phase support for monitoring glibenclamide residues. The
synthesized glibenclamide-MIP showed higher selectivity and enrichment ability towards
glibenclamide than glimepiride and metformine. The percentage of rebinding and selecti-
vity were assessed by solid phase extraction and a specific adsorption capacity of 45 mg g–1
of glibenclamide on MIP was estimated. Glibenclamide-MIP SPE cartridge was success-
fully applied in the evaluation of equipment surface during a pharmaceutical industry
cleaning process, prior to HPLC analysis. This could be a preventive action during multi-
-product manufacture.
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